⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CYTK News
Cytokinetics Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cytokinetics, Incorporated (CYTK) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
CYTK
Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)
globenewswire.com
CYTK
Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
globenewswire.com
CYTK
Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
CYTK
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
The Law Offices of Frank R. Cruz Announces Investigation of Cytokinetics, Incorporated (CYTK) on Behalf of Investors
businesswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cytokinetics, Incorporated (CYTK) And Encourages Investors to Connect
accessnewswire.com
CYTK
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CYTK
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CYTK
Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Stockholders to Inquire about Securities Investigation
accessnewswire.com
CYTK